The present invention relates to new compounds, a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy, such as provide compounds having a selective inhibiting effect at GSK3.

 
Web www.patentalert.com

< Modulators of TNF-alpha signaling

< Treatment of inflammatory disorders with praziquantel

> Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors

> Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors

~ 00280